Stockholm, Sweden

Agneta Franksson


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Agneta Franksson: Innovator in Cardiac Technology

Introduction

Agneta Franksson is a notable inventor based in Stockholm, Sweden. She has made significant contributions to the field of cardiac technology, particularly in methods for detecting and treating tachyarrhythmia. With a total of 2 patents to her name, her work has the potential to improve patient outcomes in heart health.

Latest Patents

Franksson's latest patents include a method for detecting tachyarrhythmia of the heart by measuring the partial pressure of gases dissolved in the blood. This innovative approach utilizes the partial oxygen pressure (pO₂) to identify rapid variations that may indicate tachyarrhythmia. Additionally, she has developed an apparatus for treating this condition, which includes a sensor for measuring gas pressures and an evaluation unit that triggers treatment based on the detected changes. Another significant patent involves a method and arrangement for calculating a physiological function, where she filters out signal components from measurement signals to focus on the parameters of interest.

Career Highlights

Throughout her career, Agneta Franksson has worked with prominent companies such as Pacesetter AB and Siemens Aktiengesellschaft. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in medical technology.

Collaborations

Franksson has collaborated with notable professionals in her field, including Kurt Hoegnelid and Nils Holmstroem. These partnerships have likely enriched her work and expanded the impact of her inventions.

Conclusion

Agneta Franksson's contributions to cardiac technology through her innovative patents demonstrate her commitment to improving heart health. Her work continues to influence the medical field and offers promising solutions for patients with tachyarrhythmia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…